Home / Peptide legality / By country / Belgium
Are peptides legal in Belgium?
Peptides are legal in Belgium only as authorised prescription medicines (e.g. semaglutide, somatropin) dispensed via pharmacies; unapproved 'research' peptides such as BPC-157 and TB-500 have no marketing authorisation and cannot be lawfully sold or supplied for human use in Belgium.
Legal status overview
Peptides are restricted in Belgium: they are lawful only as medicines that hold a marketing authorisation and are dispensed on prescription, while unapproved research peptides may not be marketed for human use. The Federal Agency for Medicines and Health Products (FAMHP) is the competent regulator, applying the Law of 25 March 1964 on medicines and the Royal Decree of 14 December 2006; a product sold strictly for in-vitro research falls outside the 'medicine' definition, but the moment therapeutic claims are made it becomes an unauthorised medicine subject to enforcement. Prescription-medicine peptides like GLP-1 agonists are further constrained by dedicated Royal Decrees on prescribing and delivery.
Key points
- The Federal Agency for Medicines and Health Products (FAMHP) is Belgium's competent authority responsible for the quality, safety and efficacy of medicines and health products, and is the primary regulator of peptides used as medicines. [1]
- In Belgium, a medicine, including any peptide presented for human therapeutic use, may only be marketed if it is authorised or registered, so unapproved peptides marketed for human use are unlawful. [2]
- Under Belgium's Law of 25 March 1964 and the Royal Decree of 14 December 2006, a synthetic peptide sold and used exclusively for in-vitro research does not fall within the definition of a 'medicine', placing genuine research-only supply outside FAMHP's medicines scope. [4]
- FAMHP enforcement in Belgium targets operators who sell research peptides with therapeutic claims (such as weight loss, tendon repair, or hair regrowth), which reclassifies the product as an unauthorised medicine. [4]
- For GLP-1 receptor agonists, Belgium published a Royal Decree in February 2023 subjecting exports to prior authorisation and a further Royal Decree in November 2023 establishing conditions for their prescription and delivery, with off-label obesity use restricted. [5]
- Belgian customs may query incoming shipments of peptides and can request proof of research purpose, and personally importing unauthorised peptides for human use is not a recognised legal pathway in Belgium. [3]
- The FAMHP has intensified enforcement against illegal medicines in Belgium, increasing investigations into illegal medicines and devices by 30% and stepping up pharmacy inspections. [6]
Compound-by-compound status
| BPC-157 | BPC-157 is not an authorised medicine in Belgium and may only be handled as an in-vitro research chemical; selling it for human use with therapeutic claims makes it an unauthorised medicine that the FAMHP can penalise. [4] |
|---|---|
| Semaglutide / tirzepatide (GLP-1 agonists) | GLP-1 peptides such as semaglutide are legal in Belgium only as authorised prescription medicines, and since 2023 Royal Decrees impose specific conditions on their prescription and delivery, with off-label obesity use limited. [5] |
| TB-500 (thymosin beta-4) | TB-500 has no marketing authorisation as a medicine in Belgium and falls outside FAMHP's medicines scope only if sold strictly for in-vitro research without therapeutic claims; marketing it for human use is unlawful. [4] |
| Human growth hormone (HGH / somatropin) | HGH/somatropin is regulated in Belgium as a prescription medicine that may only be marketed if authorised or registered, so supply without authorisation or a prescription is not lawful. [2] |
Frequently asked questions
Can I buy peptides in Belgium without a prescription?
No, in Belgium peptides intended for human use are medicines that may only be marketed if authorised, and prescription-only peptides must be dispensed through a pharmacy; only genuine in-vitro research supply (no human-use claims) sits outside this framework. [2]
Is BPC-157 legal in Belgium?
BPC-157 is not an authorised medicine in Belgium; it can only be handled as an in-vitro research compound, and the FAMHP penalises anyone selling it for human use with therapeutic claims. [4]
Can I import peptides into Belgium for personal use?
Personally importing unauthorised peptides for human use is not a lawful pathway in Belgium, and Belgian customs may stop shipments and request proof of research purpose; authorised prescription peptides should instead be obtained through a Belgian pharmacy. [3]
Is semaglutide (Ozempic®/Wegovy®) restricted in Belgium?
Yes, semaglutide is a prescription-only medicine in Belgium, and Royal Decrees adopted in 2023 set specific conditions on prescribing and delivery of GLP-1 agonists and restrict off-label use for obesity. [5]
Does Belgium actually enforce the rules on illegal peptides and medicines?
Yes, the FAMHP has increased investigations into illegal medicines and devices by 30% and expanded pharmacy inspections, and Sciensano assists with testing suspected falsified or illegal products. [6]
Sources
- Belgian Federal Agency for Medicines & Health Products (FAMHP), official overview (retrieved 2026-09-22)
- FAMHP, Authorised medicines in Belgium (retrieved 2026-09-22)
- Uptide, EU Regulations (Belgium / FAMHP section) (retrieved 2026-09-22)
- Research peptides in Belgium 2026: a guide to the FAMHP/AFMPS framework (retrieved 2026-09-22)
- EMA multistakeholder workshop, Shortages of GLP-1 receptor agonists: Mitigation measures Belgium (FAMHP, S. Schotte) (retrieved 2026-09-22)
- News.belgium, Federal Agency for Medicines and Health Products (FAMHP) (retrieved 2026-09-22)
Last researched: 2026-09-22.